04/02/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/2/2020. This 20-page revised guidance document provides blood establishments that collect blood or blood components, including Source Plasma, with the Food and Drug Administration’s revised donor deferral recommendations for individuals with increased risk for transmitting human immunodeficiency virus (HIV) infection. There is a significant shortage in the supply of blood in the United States, which early implementation of the recommendations in this guidance may help to address (even though the recommendations in this guidance are broadly applicable beyond the COVID-19 public health emergency). (PDF)
04/01/2020 12:00 AM EDT
Source: Centers for Medicare and Medicaid Services (CMS). Published: 4/1/2020. This web page provides information and guidance related to how the Centers for Medicare and Medicaid Services is easing the burden and helping providers care for Americans by offering new waivers and flexibilities during the COVID-19 public health emergency. (Text)
04/01/2020 12:00 AM EDT
Source: National Academies Press (NAP). Published: 4/1/2020. In response to a request from the Office of Science and Technology Policy (OSTP), the National Academies of Sciences, Engineering, and Medicine convened a standing committee of experts to help inform OSTP on critical science and policy issues related to emerging infectious diseases and other public health threats. This three-page publication responds to questions concerning the possibility that the SARS-Cov-2 virus could be spread by conversation, in addition to sneeze/cough-induced droplets. (Text)
04/01/2020 12:00 AM EDT
Source: American Public Health Association (APHA). Published: 4/2020. This one-hour, 32-minute webinar is part of a COVID-19 Conversations series, co-sponsored with the National Academy of Medicine. A panel of experts discuss benefit-risk analysis of social/physical distancing strategies, including for vulnerable populations; examine strategies for mitigating mental health impacts; and explore what science is available to guide eventual relaxation of measures. (Video or Multimedia)
03/31/2020 12:00 AM EDT
Source: Federal Emergency Management Agency [Department of Homeland Security] (FEMA). Published: 3/31/2020. This three-page document describes how community leaders can best use Community Emergency Response Team (CERT) volunteers to respond to coronavirus (COVID-19). It also provides a list of Lessons Learned Related to COVID-19 Operations and CERT Volunteers. (PDF)
03/31/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/31/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular Laboratory Developed Test (LDT) COVID-19 Authorized Test (Molecular LDT COVID-19 Authorized Test) that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
03/31/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/31/2020. This one-page letter authorizes the emergency use of the Yale New Haven Hospital SARS-CoV-2 PCR Test, which is eligible for authorization under the March 31, 2020, Emergency Use Authorization (EUA) for Molecular-based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2 (Molecular LDT COVID-19 Authorized Test). (PDF)
03/31/2020 12:00 AM EDT
Source: Dart Center for Journalism and Trauma [Columbia University]. Published: 3/31/2020. This 46-minute webinar, part of Reporting and Covid-19: A Webinar Series for Journalists, discusses how journalists can best develop the right expert sources, and how they can effectively bridge complicated medical science and public understanding. (Video or Multimedia)
03/31/2020 12:00 AM EDT
Source: United Kingdom Department of Health (DH). Published: 3/31/2020. This guidance is primarily designed to assist people who are required to manage bodies of deceased persons who are suspected or confirmed as being infected with coronavirus (COVID-19). (Text)
03/31/2020 12:00 AM EDT
Source: WebJunction. Published: 3/31/2020. This one-hour webinar presents a newly published call to action, offering strategies for public libraries to consider as they determine a local response to the nationwide opioid crisis. Panelists share resources, including ideas for organizations to partner with, additional perspectives to consider, and strategies for getting started. This web page also provides Related Resources and Links. (Video or Multimedia)
03/30/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/30/2020. These public health recommendations have been updated to accommodate new scientific evidence, evolving epidemiology, and the need to simplify risk stratification. New recommendations are based on growing evidence of transmission risk from infected persons without symptoms or before the onset of recognized symptoms; increased community transmission in many parts of the country; and continued focus on reducing transmission through social distancing of individuals in affected areas. (Text)
03/29/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 3/29/2020. The target audiences for this 48-page document are ministries of health responsible for national essential medicines lists or reimbursement lists, and policy or decision-makers considering establishing systems for selecting medicines or updating medicines lists as part of efforts to ensure access to medicines and universal health coverage. The chief intended use of the World Health Organization Model List is to provide a blueprint on which countries can base their own national lists. (PDF)
03/27/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/27/2020. The Food and Drug Administration (FDA) has issued this 16-page guidance, updated on March 27, 2020, to provide general considerations to assist sponsors in assuring the safety of trial participants in the conduct of clinical trials of medical products, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity during the COVID-19 (coronavirus) pandemic. It addresses the challenges that may lead to difficulties in meeting protocol-specified procedures, including administering or using the investigational product or adhering to protocol-mandated visits and laboratory/diagnostic testing. (PDF)
03/27/2020 12:00 AM EDT
Source: National Academies Press (NAP). Published: 3/27/2020. In response to a request from the Office of Science and Technology Policy (OSTP), the National Academies of Sciences, Engineering, and Medicine convened a standing committee of experts to help inform OSTP on critical science and policy issues related to emerging infectious diseases and other public health threats, including the COVID-19 pandemic. A previous Rapid Expert Consultation, dated March 15, 2020, provided feedback concerning issues of COVID-19 virus survival on surfaces and in the air, and virus/disease incubation period. This 10-page publication, updated on March 27, 2020, provides an update and elaboration on these issues, as well as some caveats about the work performed so far and as yet unmet needs. (Text)
03/27/2020 12:00 AM EDT
Source: Henry J. Kaiser Family Foundation. Published: 3/27/2020. A surge in patients with the new coronavirus disease (COVID-19) would challenge the ability of the U.S. healthcare system to treat all patients, including those in need of care for other conditions. The charts on this web page, developed with the Peterson Center on Healthcare, highlight available cross-national data on the healthcare workforce, hospital resources, and at-risk populations in select countries. Additional charts explore coverage and affordability barriers that may limit access to care or cause serious financial burden for those needing COVID-19 treatment. (Text)
03/27/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/27/2020. This resource is intended for healthcare facilities that are receiving or are preparing to receive patients with suspected or confirmed coronavirus disease 2019 (COVID-19). This includes healthcare facilities providing either inpatient or outpatient services. It should be used to guide implementation of procedures at triage that can be effective at preventing transmission of SARS-CoV-2 (COVID-19 virus) to patients and healthcare workers. (Text)
03/27/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/27/2020. This resource is intended to guide national-level coordination, healthcare facilities, and implementing partners in considering and planning high-priority infection prevention and control activities to prevent healthcare-associated transmission of SARS-CoV-2 (COVID-19 virus). Aspects of this guidance are relevant for all countries, but a focus is placed on priorities for low- and middle-income settings given resource constraints. (Text)
03/27/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/27/2020. This web page provides guidance on the identification or screening of healthcare workers and inpatients with suspected COVID-19 in non-U.S. healthcare settings. Rationale, requirements, and considerations are discussed for three broad case identification strategies: passive, enhanced passive, and active. (Text)
03/27/2020 12:00 AM EDT
Source: Michigan Department of Health and Human Services (MDHHS). Published: 3/27/2020. This 77-page document serves as guidance for clinicians providing care in Michigan during the COVID-19 outbreak. It is also a guide for hospital administrators who should be actively planning, or already implementing, Crisis Standards of Care in their facilities given the current status of the outbreak as of the date of this publication. It is adapted from the Department of Defense and Minnesota Department of Health. (PDF)
03/26/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/26/2020. This web page provides answers to frequently asked questions for entities who use 3D printing of devices, accessories, components, and/or parts during the COVID-19 emergency. The Food and Drug Administration recognizes that the public may seek to use 3D printing to assist in meeting demand for certain products during the COVID-19 pandemic. (Text)
03/26/2020 12:00 AM EDT
Source: American Medical Association (AMA). Published: 3/26/2020. This web page provides practical strategies for health system leadership to consider in support of their physicians and care teams during COVID-19. Now more than ever, it's important for health systems and healthcare organizations to create and ensure an infrastructure and resources to support physicians, nurses, and care team members. (Text)
03/26/2020 12:00 AM EDT
Source: Dart Center for Journalism and Trauma [Columbia University]. Published: 3/26/2020. When the first case of COVID-19 in the U.S. was confirmed in Washington State, Seattle’s journalists found themselves at the center of the coronavirus maelstrom, covering a devastating community outbreak with international consequences while navigating their own safety and ethical concerns. This 49-minute webinar, part of Reporting and Covid-19: A Webinar Series for Journalists, discusses the lessons Seattle can teach news teams in other communities as COVID-19 arrives. (Video or Multimedia)
03/23/2020 12:00 AM EDT
Source: Association of State and Territorial Health Officials (ASTHO). Published: 3/23/2020. Demand for ventilation resources has increased due to the COVID-19 response. This two-page document lists examples of states and institutions that have started recommending or implementing crisis standards of care (CSC) that direct the allocation and use of ventilators; discusses key considerations; and lists key resources. (PDF)
03/18/2020 12:00 AM EDT
Source: U.S. Department of Homeland Security (DHS). Published: 3/18/2020. This two-page document is for executives to help them think through physical, supply chain, and cybersecurity issues that may arise from the spread of novel coronavirus (COVID-19). It lists actions for infrastructure protection, the supply chain, and cybersecurity for organizations, workforce, and consumers. (PDF)
03/01/2020 12:00 AM EST
Source: Thalassaemia International Federation (TIF). Published: 3/2020. This 16-page document is an informational leaflet about COVID-19, with a special focus on the challenges it presents for patients affected by thalassaemia and sickle cell disease (SCD). (Text)
03/01/2020 12:00 AM EST
Source: American Medical Association (AMA). Published: 3/2020. The AMA (American Medical Association) Code of Medical Ethics offers this foundational guidance for healthcare professionals and institutions responding to the COVID-19 pandemic in Opinion 8.3, "Physicians' Responsibilities in Disaster Response and Preparedness," and Opinion 11.1.3, "Allocating Limited Health Care Resources." (Text)
03/01/2020 12:00 AM EST
Source: Sphere Project. Published: 3/2020. This web page provides the Sphere Project's and its partners’ guidance on the COVID-19 response in multiple languages, additional resources based on humanitarian standards, and information on upcoming learning events. (Text)
09/01/2019 12:00 AM EDT
Source: Federal Emergency Management Agency [Department of Homeland Security] (FEMA). Published: 9/2019. This 30-minute presentation highlights how social media can be an effective communication channel in disasters, how emergency managers can incorporate data provided by the general public into actionable intelligence during an emergency response, and how citizens can assist with data collection, processing, and analysis. (Video or Multimedia)
No hay comentarios:
Publicar un comentario